Adze Biotechnology
Business Services · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
805 Lake St PMB 126, Oak Park, Illinois,...Phone Number
(917) 743-9401Website
www.adzebiotech.comRevenue
<$5 MillionIndustry
About Adze Biotechnology
Adze Biotechnology is a clinical stage company focused on developing a platform of oncolytic immunotherapies aimed at treating solid tumors and enhancing anti-tumor immunity. Their innovative approach utilizes a proprietary oncolytic viral backbone for systemic delivery of immunotherapies and checkpoint inhibitors. The company targets multiple solid tumor indications, including melanoma, hepatocellular carcinoma, and triple-negative breast cancer. Adze Biotechnology aims to build strategic partnerships with major pharmaceutical companies to advance their drug candidates and improve patient outcomes.Explore more
SIC Code 87,873NAICS Code 54,541Show moreAdze Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Adze Biotechnology
Compare insights from companies similar to Adze Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Adze Biotechnology Tech Stack
A closer look at the technologies used by Adze Biotechnology
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Adze Biotechnology
Sign Up For FreeTo access detailed company insights
Adze Biotechnology is a clinical stage company focused on developing a platform of oncolytic immunotherapies aimed at treating solid tumors and enhancing anti-tumor immunity. Their innovative approach utilizes a proprietary oncolytic viral backbone for systemic delivery of immunotherapies and checkpoint inhibitors. The company targets multiple soli... Read More
